Systematic Financial Management LP Concert Pharmaceuticals, Inc. Transaction History

Systematic Financial Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$11.25 - $16.17 $820,237 - $1.18 Million	-72,910 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$12.82 - $17.88 $10,127 - $14,125	790 Added 1.1%	72,910 $1.08 Million
Q2 2018 Aug 08, 2018	BUY	$16.83 - $21.66 $108,385 - $139,490	6,440 Added 9.81%	72,120 $1.21 Million
Q1 2018 May 09, 2018	BUY	$19.24 - $28.03 $1.26 Million - $1.84 Million	65,680 New	65,680 $1.5 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.